CC

Casdin Capital Portfolio holdings

AUM $1.61B
1-Year Est. Return 69.26%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+69.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.01B
AUM Growth
+$69M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
62
New
Increased
Reduced
Closed

Top Buys

1
+$211M
2
+$150M
3
+$140M
4
PACB icon
Pacific Biosciences
PACB
+$88.6M
5
DNA icon
Ginkgo Bioworks
DNA
+$87.7M

Top Sells

1
+$49.1M
2
+$45.3M
3
+$22.1M
4
FULC icon
Fulcrum Therapeutics
FULC
+$12.1M
5
CLOV icon
Clover Health Investments
CLOV
+$9.68M

Sector Composition

1 Healthcare 91.34%
2 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$347M 8.66%
12,203,669
2
$320M 7.99%
7,566,292
+126,185
3
$225M 5.62%
2,360,186
4
$204M 5.09%
7,990,652
+2,990,652
5
$202M 5.03%
3,400,000
6
$189M 4.71%
1,000,000
7
$171M 4.26%
+13,971,334
8
$159M 3.98%
1,550,000
9
$154M 3.83%
+12,389,082
10
$143M 3.56%
3,038,167
11
$116M 2.89%
3,668,574
+293,516
12
$107M 2.67%
1,000,000
13
$102M 2.54%
1,100,000
+215,000
14
$101M 2.51%
4,330,000
15
$99.9M 2.49%
2,165,000
16
$89.8M 2.24%
+7,718,593
17
$85.8M 2.14%
1,700,000
+90,000
18
$83.5M 2.08%
+180,070
19
$80.7M 2.01%
3,206,380
20
$77M 1.92%
2,800,000
+495,000
21
$75.6M 1.89%
1,193,335
22
$74.1M 1.85%
+3,586,818
23
$71.2M 1.78%
818,820
24
$71M 1.77%
+5,487,910
25
$56M 1.4%
1,745,000
1
2 3